Clinical Trial Update: Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

A phase 2 clinical trial evaluating the efficacy and safety of Astragalus membranaceus in mild-to-moderate Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Astragalus membranaceus (Astragalus membranaceus)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED